Edition:
United Kingdom

GlaxoSmithKline Consumer Healthcare Ltd (GLSM.NS)

GLSM.NS on National Stock Exchange of India

6,218.80INR
23 May 2018
Change (% chg)

Rs282.40 (+4.76%)
Prev Close
Rs5,936.40
Open
Rs6,000.00
Day's High
Rs6,284.00
Day's Low
Rs5,951.55
Volume
55,066
Avg. Vol
18,403
52-wk High
Rs6,940.25
52-wk Low
Rs4,851.00

Latest Key Developments (Source: Significant Developments)

GSK To Review Of Horlicks, Consumer Nutrition Products To Fund Novartis Deal
Tuesday, 27 Mar 2018 

March 27 (Reuters) - Glaxosmithkline Plc ::GLAXOSMITHKLINE - TRANSACTION WITH NOVARTIS EXPECTED TO BE ACCRETIVE TO ADJUSTED EARNINGS IN 2018 AND THEREAFTER, AND TO STRENGTHEN CASH FLOW GENERATION.GSK ALSO TO INITIATE STRATEGIC REVIEW OF HORLICKS AND OTHER CONSUMER NUTRITION PRODUCTS TO SUPPORT TRANSACTION FUNDING..‍REVIEW WILL INCLUDE AN ASSESSMENT OF GROUP'S SHAREHOLDING IN INDIAN SUBSIDIARY, GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD​.STRATEGIC REVIEW WILL INCLUDE AN ASSESSMENT OF GSK'S 72.5% SHAREHOLDING IN COMPANY.‍EXPECTS OUTCOME OF STRATEGIC REVIEW TO BE CONCLUDED AROUND END OF 2018​.GLAXOSMITHKLINE - CONSUMER HEALTHCARE BUSINESS TO CONTINUE TO INVEST IN GROWTH OPPORTUNITIES FOR OTC, ORAL HEALTH BRANDS, SUCH AS SENSODYNE AND ENO.GLAXOSMITHKLINE - ACTIVELY INVESTING IN PHARMACEUTICAL, VACCINES BUSINESSES, INCLUDING BUILDING NEW MANUFACTURING CAPACITY IN VEMGAL, KARNATAKA, NASHIK.GLAXOSMITHKLINE - BUYOUT TO BE STRUCTURED AS CANCELLATION OF NOVARTIS' SHARES IN JV IN CONSIDERATION OF JOINT VENTURE PAYING BUYOUT PRICE TO NOVARTIS.GSK HAS ENTERED INTO A COMMITTED FACILITIES AGREEMENT TO SUPPORT FUNDING OF BUYOUT.AGREED TO PAY BREAK FEE OF $200 MILLION IN NOVARTIS DEAL.JOINT VENTURE WILL CONTINUE TO PAY DIVIDENDS TO GSK AND NOVARTIS IN ACCORDANCE WITH ITS ESTABLISHED PRACTICE UNTIL COMPLETION.  Full Article

India's Glaxosmithkline Consumer Healthcare Sept qtr profit up about 4 pct
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Glaxosmithkline Consumer Healthcare Ltd :Sept quarter net profit 1.92 billion rupees versus profit of 1.84 billion rupees last year.Sept quarter revenue from operations 11.15 billion rupees versus 11.93 billion rupees last year.  Full Article

Glaxosmithkline Consumer Healthcare Dec-qtr profit down about 8 pct
Monday, 13 Feb 2017 

Glaxosmithkline Consumer Healthcare Ltd : Dec quarter net profit 1.36 billion rupees . Dec quarter net sales 9.22 billion rupees . Net profit in dec quarter last year was 1.49 billion rupees as per Ind-AS; net sales was 10.56 billion rupees .Says tenure of Subidh Bharagava as non executive chairman been extended.  Full Article

Glaxosmithkline Consumer Healthcare June-qtr profit up about 2.9 pct
Friday, 5 Aug 2016 

Glaxosmithkline Consumer Healthcare : June-quarter net profit 1.61 billion rupees . June-quarter net sales 10.03 billion rupees .Net profit in June quarter last year was 1.56 billion rupees as per Ind-AS; net sales was 10.19 billion rupees.  Full Article

GlaxoSmithKline Consumer Healthcare says no financial impact due to temporary stoppage at Nabha plant
Friday, 17 Jun 2016 

GlaxoSmithKline Consumer Healthcare Ltd : No material financial impact on co on temporary stoppage of operations at Nabha plant .  Full Article

RPT-Nestle, other food groups likely suitors for GSK's Horlicks - sources

LONDON/NEW YORK, March 27 Food giants Nestle , Kraft Heinz and Unilever are expected to bid for GlaxoSmithKline's Horlicks health nutrition business, which could fetch more than $4 billion, according to people familiar with the matter.